CRISPR Therapeutics AG (CRSP)
USD 41.06
(-8.0%)
USD 41.06
(-8.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 240.95 Million USD | 318.32% |
| 2022 | -109.81 Million USD | -112.27% |
| 2021 | 895.12 Million USD | 432.93% |
| 2020 | -268.86 Million USD | -343.92% |
| 2019 | 110.22 Million USD | 199.62% |
| 2018 | -110.64 Million USD | -284.16% |
| 2017 | -28.8 Million USD | 22.31% |
| 2016 | -37.07 Million USD | -200.78% |
| 2015 | -12.32 Million USD | -714.67% |
| 2014 | -1.51 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | -10.55 Million USD | 81.31% |
| 2024 Q1 | -51.29 Million USD | -128.5% |
| 2024 Q2 | -56.45 Million USD | -10.07% |
| 2023 Q2 | 25.36 Million USD | -56.12% |
| 2023 Q4 | 180 Million USD | 868.51% |
| 2023 Q3 | -23.42 Million USD | -192.34% |
| 2023 FY | 239.75 Million USD | 318.32% |
| 2023 Q1 | 57.8 Million USD | 948.0% |
| 2022 Q4 | -6.81 Million USD | 82.41% |
| 2022 FY | -109.81 Million USD | -112.27% |
| 2022 Q1 | -30.46 Million USD | 75.14% |
| 2022 Q2 | -33.76 Million USD | -10.82% |
| 2022 Q3 | -38.76 Million USD | -14.81% |
| 2021 FY | 895.12 Million USD | 432.93% |
| 2021 Q3 | -22.13 Million USD | -102.53% |
| 2021 Q4 | -122.57 Million USD | -453.74% |
| 2021 Q2 | 873.25 Million USD | 4523.12% |
| 2021 Q1 | -19.74 Million USD | 75.97% |
| 2020 Q2 | -59.33 Million USD | -9.81% |
| 2020 Q3 | -70.86 Million USD | -19.42% |
| 2020 Q1 | -54.03 Million USD | -291.24% |
| 2020 FY | -268.86 Million USD | -343.92% |
| 2020 Q4 | -82.17 Million USD | -15.96% |
| 2019 Q2 | -39.21 Million USD | -37.44% |
| 2019 FY | 110.22 Million USD | 199.62% |
| 2019 Q4 | 28.25 Million USD | -81.73% |
| 2019 Q3 | 154.68 Million USD | 494.45% |
| 2019 Q1 | -28.53 Million USD | 0.54% |
| 2018 Q4 | -28.68 Million USD | 26.93% |
| 2018 Q3 | -39.25 Million USD | -59.94% |
| 2018 FY | -110.64 Million USD | -284.16% |
| 2018 Q2 | -24.54 Million USD | -35.15% |
| 2018 Q1 | -18.16 Million USD | -247.71% |
| 2017 FY | -28.8 Million USD | 22.31% |
| 2017 Q2 | -13.53 Million USD | -11.87% |
| 2017 Q1 | -12.1 Million USD | 8.51% |
| 2017 Q4 | 12.29 Million USD | 179.54% |
| 2017 Q3 | -15.45 Million USD | -14.18% |
| 2016 FY | -37.07 Million USD | -200.78% |
| 2016 Q4 | -13.22 Million USD | -25.94% |
| 2016 Q3 | -10.5 Million USD | -34.53% |
| 2016 Q2 | -7.8 Million USD | -41.02% |
| 2016 Q1 | -5.53 Million USD | 6.6% |
| 2015 Q2 | -1.48 Million USD | -27.66% |
| 2015 Q1 | -1.16 Million USD | 0.0% |
| 2015 Q3 | -3.74 Million USD | -152.29% |
| 2015 FY | -12.32 Million USD | -714.67% |
| 2015 Q4 | -5.92 Million USD | -58.1% |
| 2014 FY | -1.51 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -154.38% |
| IO Biotech, Inc. | -756 Thousand USD | 31972.487% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -56729.245% |
| Organovo Holdings, Inc. | -5.38 Million USD | 4571.256% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -123652.491% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -7860.225% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1018.385% |
| Savara Inc. | -44.26 Million USD | 644.386% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 251095.833% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 3494.703% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 873.096% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 2316984.615% |
| Soligenix, Inc. | 97.31 Thousand USD | -247514.35% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 50876.217% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 20129.593% |
| Century Therapeutics, Inc. | -10.8 Million USD | 2329.216% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 143526.19% |
| Precision BioSciences, Inc. | 40.47 Million USD | -495.365% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 1.464% |
| Kura Oncology, Inc. | -849 Thousand USD | 28481.154% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -9386.509% |
| Dyadic International, Inc. | 922.95 Thousand USD | -26006.958% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 459.078% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 327.054% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -143.294% |
| Autolus Therapeutics plc | -4.86 Million USD | 5050.812% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1044.086% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -482.216% |
| GRI Bio, Inc. | 10.84 Million USD | -2122.636% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2873.754% |
| IGM Biosciences, Inc. | -211.66 Million USD | 213.841% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -289.021% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 16096.643% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 823205.828% |
| Opthea Limited | 21.72 Thousand USD | -1109273.849% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 12171.944% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 77082.748% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 92420.307% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -101.211% |
| Surrozen, Inc. | -27.23 Million USD | 984.892% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cingulate Inc. | -582.91 Thousand USD | 41436.174% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 20098.34% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -719.941% |
| Acelyrin, Inc. | -115 Thousand USD | 209626.957% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -3871.962% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 359034.025% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -55.665% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 345.33% |
| ADMA Biologics, Inc. | 88.21 Million USD | -173.137% |
| PureTech Health plc | -1.6 Million USD | 15131.566% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 931.801% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 55238.673% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -29944.389% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 318.081% |
| Synaptogenix, Inc. | -6347.00 USD | 3796476.241% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 472562.745% |
| ChromaDex Corporation | 50.78 Million USD | -374.51% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1903.853% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 86.291% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -100.007% |
| Better Therapeutics, Inc. | -2.72 Million USD | 8929.461% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 314.83% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 28.728% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 631.618% |
| Seer, Inc. | 7.02 Million USD | -3329.002% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -7230.575% |
| Gritstone bio, Inc. | -6.26 Million USD | 3949.137% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 21846.931% |
| Avid Bioservices, Inc. | 7.31 Million USD | -3192.648% |
| Insmed Incorporated | 239.63 Million USD | -0.551% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 1039.509% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -37549.375% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 345.465% |
| MediWound Ltd. | 3.57 Million USD | -6634.377% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -200696.667% |
| Fortress Biotech, Inc. | 57.85 Million USD | -316.497% |
| OmniAb, Inc. | 14.66 Million USD | -1542.844% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -91.812% |
| Zai Lab Limited | 170.9 Million USD | -40.99% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -194.29% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1419.844% |
| Veracyte, Inc. | 248.14 Million USD | 2.898% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -9795.524% |
| FibroGen, Inc. | 128.9 Million USD | -86.927% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| ContextLogic Inc. | 59 Million USD | -308.4% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 164015.646% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 42722795.035% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1353.556% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 92.91% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -727.203% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -61842.416% |
| ImmuCell Corporation | 4.39 Million USD | -5380.902% |
| Fortrea Holdings Inc. | 424 Million USD | 43.171% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 379.638% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 21846.931% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 419.003% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 38.064% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1334.006% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 585.338% |
| Vaxxinity, Inc. | -2.23 Million USD | 10885.855% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 26.257% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2227.864% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -4462048.148% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 3491.045% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1101.656% |
| Senti Biosciences, Inc. | -2.68 Million USD | 9080.842% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -165164.746% |
| Apollomics, Inc. | 127 Thousand USD | -189629.134% |
| 89bio, Inc. | -273 Thousand USD | 88362.271% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -0.092% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 46729.485% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 6885.582% |
| Ardelyx, Inc. | 106.66 Million USD | -125.908% |
| Pluri Inc. | 322 Thousand USD | -74731.056% |
| Prothena Corporation plc | -129.2 Million USD | 286.497% |
| Pulmatrix, Inc. | -8.22 Million USD | 3031.338% |
| Celularity Inc. | 6.75 Million USD | -3467.076% |
| MeiraGTx Holdings plc | 287 Thousand USD | -83856.794% |
| Omeros Corporation | -69.77 Million USD | 445.313% |
| Ainos, Inc. | -253.73 Thousand USD | 95064.392% |
| Humacyte, Inc. | -76.55 Million USD | 414.769% |
| Mesoblast Limited | -9.81 Million USD | 2554.977% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1688.476% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -286.259% |
| Blueprint Medicines Corporation | 236.58 Million USD | -1.848% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 16997.335% |
| Summit Therapeutics Inc. | -2.05 Million USD | 11853.951% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 5122.009% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 8572.433% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 160.421% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -8581.269% |
| Cytokinetics, Incorporated | -322.59 Million USD | 174.693% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -27849.728% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 70761.584% |
| Roivant Sciences Ltd. | 109.23 Million USD | -120.585% |
| Evogene Ltd. | 1.39 Million USD | -17123.445% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 648.725% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -3414.015% |
| BioLineRx Ltd. | 1.1 Million USD | -21646.931% |
| Atai Life Sciences N.V. | -5000.00 USD | 4819220.0% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -48479.839% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -49.324% |
| MediciNova, Inc. | 979.7 Thousand USD | -24494.75% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 385.767% |
| MiMedx Group, Inc. | 266.84 Million USD | 9.701% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 72.378% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 77827.742% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 2008066.667% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 37258.534% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4819220.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 415.499% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 9890.979% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -12.736% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 25706.376% |
| Allakos Inc. | -6.14 Million USD | 4023.726% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 449.232% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 49.368% |
| BioAtla, Inc. | -103.73 Million USD | 332.289% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 199.233% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 77577.814% |
| Precigen, Inc. | 106 Thousand USD | -227216.981% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| XOMA Corporation | 3.86 Million USD | -6140.767% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 443.805% |
| Incyte Corporation | 3.44 Billion USD | 92.997% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1528.741% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1833.836% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 830982.759% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1853507592.308% |
| UroGen Pharma Ltd. | 73.35 Million USD | -228.493% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1002.66% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -2075317.743% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 127589.947% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -5848.062% |
| Chimerix, Inc. | 324 Thousand USD | -74269.136% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 545397.366% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 109141.212% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -204.222% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -41719.643% |
| Portage Biotech Inc. | -54 Thousand USD | 446314.815% |
| OncoCyte Corporation | 413 Thousand USD | -58242.857% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 5360633.927% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 12169594.949% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 108538838.739% |
| Purple Biotech Ltd. | -196 Thousand USD | 123036.735% |
| NextCure, Inc. | -3.68 Million USD | 6640.608% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 2406.912% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Generation Bio Co. | -73.91 Million USD | 426.008% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 36171.257% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -78.131% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 103960.345% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2112266.9% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 639.93 Million USD | 62.347% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Curis, Inc. | 9.81 Million USD | -2355.978% |
| Daré Bioscience, Inc. | 2.76 Million USD | -8600.274% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 14036.148% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 286.038% |
| BeiGene, Ltd. | 2.07 Billion USD | 88.409% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 8718.191% |
| Alector, Inc. | -95.05 Million USD | 353.496% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -325.056% |
| Erasca, Inc. | -3.73 Million USD | 6556.484% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 654.393% |
| Aura Biosciences, Inc. | -1.29 Million USD | 18706.641% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 49074.797% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 360666.837% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 854008.853% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -23780.674% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 87.347% |
| Histogen Inc. | 3.76 Million USD | -6293.102% |
| Fortress Biotech, Inc. | 57.85 Million USD | -316.497% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 232.825% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -185250.769% |
| Galecto, Inc. | -830 Thousand USD | 29130.843% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 103.448% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -46687.573% |
| Molecular Templates, Inc. | 50.39 Million USD | -378.135% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 420425.856% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 32.191% |
| Amarin Corporation plc | 165.54 Million USD | -45.557% |
| TG Therapeutics, Inc. | 219.1 Million USD | -9.971% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 42596.649% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 316.827% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 6815.608% |
| Onconetix, Inc. | -1.12 Million USD | 21477.172% |
| MacroGenics, Inc. | 50.52 Million USD | -376.886% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -228.265% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1165.326% |
| Adagene Inc. | 18.11 Million USD | -1230.404% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -39465.846% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -885.465% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -52.662% |
| SciSparc Ltd. | 2.19 Million USD | -10872.495% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 962038.6% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 777829.004% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 55238.673% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -341.158% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 180.094% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 84.126% |
| Psyence Biomedical Ltd. | -240.00 USD | 100398433.333% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -145.153% |
| Clene Inc. | 533 Thousand USD | -45107.505% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 25278.265% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1262.872% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 2165.298% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 533.694% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Absci Corporation | -41.84 Million USD | 675.775% |
| XBiotech Inc. | -1.74 Million USD | 13916.284% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 28922.488% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 618.508% |
| Entera Bio Ltd. | -56 Thousand USD | 430378.571% |
| Trevena, Inc. | 1.45 Million USD | -16460.55% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -377.86% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 410.518% |
| INmune Bio, Inc. | 155 Thousand USD | -155355.484% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 124102.141% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 68359.49% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 777377.419% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1323.189% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 3183138.309% |
| Jaguar Health, Inc. | 7.72 Million USD | -3019.575% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -2961.314% |
| NexImmune, Inc. | -1.02 Million USD | 23608.545% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 24488.259% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 427766.749% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 24165.855% |
| Kronos Bio, Inc. | 1.37 Million USD | -17462.391% |
| Innoviva, Inc. | 261.06 Million USD | 7.703% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -155.085% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 97.868% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 548.992% |
| Verastem, Inc. | -62 Thousand USD | 388738.71% |
| ProKidney Corp. | -3.16 Million USD | 7703.534% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Imunon, Inc. | -720 Thousand USD | 33565.879% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 82619.178% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 49444.479% |
| ImmunityBio, Inc. | -17.89 Million USD | 1446.875% |
| Korro Bio, Inc. | -3.63 Million USD | 6737.906% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -80.103% |
| Kineta, Inc. | 5.43 Million USD | -4335.045% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 23.182% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -899.437% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 36388.554% |
| Celularity Inc. | 6.75 Million USD | -3467.076% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -5904.386% |
| CalciMedica, Inc. | -58 Thousand USD | 415541.379% |
| Cibus, Inc. | 1.42 Million USD | -16844.866% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 348.536% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -729.31% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 64526.738% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1028.647% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 880.677% |
| Annexon, Inc. | -3.26 Million USD | 7475.451% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 11888.454% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 677.32% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 20694.53% |
| Moderna, Inc. | 2.15 Billion USD | 88.819% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 60489.975% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 69.049% |
| Vor Biopharma Inc. | -3.49 Million USD | 7000.229% |
| Eyenovia, Inc. | - USD | -Infinity% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 803286.667% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -39.317% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 3972.645% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -131.468% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 64.602% |
| Immunocore Holdings plc | 248.39 Million USD | 2.993% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 406.283% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 730269.697% |
| Alkermes plc | 1.37 Billion USD | 82.472% |
| Arcellx, Inc. | 108.27 Million USD | -122.533% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 197833.446% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 17447.444% |
| Sagimet Biosciences Inc. | 2 Million USD | -11947.8% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1239.164% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 254931.58% |
| Moolec Science SA | -143.3 Thousand USD | 168242.075% |
| Biomea Fusion, Inc. | -4.2 Million USD | 5835.682% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | -123.5 Million USD | 295.101% |
| Mereo BioPharma Group plc | 7.42 Million USD | -3144.762% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -5403.792% |
| Royalty Pharma plc | 1.79 Billion USD | 86.568% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 443.781% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 6671085.604% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 17497.545% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -104033.696% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 316.271% |
| Humacyte, Inc. | -76.55 Million USD | 414.769% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 25485.862% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2112266.9% |
| Genelux Corporation | -848 Thousand USD | 28514.623% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 203453.841% |
| aTyr Pharma, Inc. | -2.38 Million USD | 10190.285% |
| Notable Labs, Ltd. | 113 Thousand USD | -213135.398% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 474983.721% |
| Mustang Bio, Inc. | -2.22 Million USD | 10929.483% |
| Immunovant, Inc. | -231 Thousand USD | 104409.957% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Vericel Corporation | 135.57 Million USD | -77.728% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 62.167% |
| Akari Therapeutics, Plc | -4000.00 USD | 6024000.0% |
| Acasti Pharma Inc. | -11 Thousand USD | 2190609.091% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 117859.521% |
| Vaxcyte, Inc. | -75 Million USD | 421.275% |
| Orgenesis Inc. | -5.72 Million USD | 4308.838% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 712.449% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| GH Research PLC | -315 Thousand USD | 76593.968% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 63343.045% |
| PepGen Inc. | -1.18 Million USD | 20451.014% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 189829.134% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 291874.336% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -363530.327% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 6212.457% |
| Belite Bio, Inc | -399 Thousand USD | 60489.975% |
| Pharming Group N.V. | 220.1 Million USD | -9.474% |
| XOMA Corporation | 3.86 Million USD | -6140.767% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 45996.381% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | -434.44 Thousand USD | 55562.436% |
| Xencor, Inc. | -85.26 Million USD | 382.613% |
| Replimune Group, Inc. | -2.65 Million USD | 9175.556% |
| Pyxis Oncology, Inc. | -2 Million USD | 12147.8% |
| Cassava Sciences, Inc. | -89.42 Million USD | 369.456% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -35.487% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1359.809% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 293948.78% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1262.872% |
| MEI Pharma, Inc. | 49.32 Million USD | -388.487% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 64014.058% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 254931.58% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 135468.539% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 28957.006% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -2586.842% |
| scPharmaceuticals Inc. | 9.78 Million USD | -2363.259% |
| HilleVax, Inc. | -2.15 Million USD | 11276.067% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -12840.709% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1606045.081% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Immunic, Inc. | -111 Thousand USD | 217177.477% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1047734.783% |
| Aptorum Group Limited | -1.11 Million USD | 21716.452% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 12406.231% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 3210210.096% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 193192.285% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 105782.456% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 33.443% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 2397433.599% |
| bluebird bio, Inc. | -4.03 Million USD | 6079.057% |
| DBV Technologies S.A. | 15.72 Million USD | -1432.019% |
| Compugen Ltd. | 31.45 Million USD | -666.034% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 854008.853% |
| Peak Bio, Inc. | 367.76 Thousand USD | -65418.301% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 26433.989% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -2909.693% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 42298.949% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -9261.15% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -882.852% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 45054.478% |
| Benitec Biopharma Inc. | 108 Thousand USD | -223007.407% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 309017.949% |
| Adicet Bio, Inc. | -6.09 Million USD | 4051.394% |
| Prime Medicine, Inc. | -147.9 Million USD | 262.913% |
| Aditxt, Inc. | -111.66 Thousand USD | 215894.376% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 45822.201% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -49276.23% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 168246.768% |
| PolyPid Ltd. | -1.82 Million USD | 13324.808% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 202584.034% |
| Invivyd, Inc. | -2.02 Million USD | 11981.46% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 233047.273% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -119.506% |
| CorMedix Inc. | -205.56 Thousand USD | 117318.163% |
| Instil Bio, Inc. | -4.75 Million USD | 5166.358% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -12020.523% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -383.799% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 3497.575% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -150.037% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 22535.382% |
| AbCellera Biologics Inc. | 38.02 Million USD | -533.678% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -353.249% |
| Surrozen, Inc. | -27.23 Million USD | 984.892% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 614.435% |
| Verona Pharma plc | -679.62 Thousand USD | 35554.31% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 27450.284% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -188.864% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -329471.069% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 239.13% |
| Shattuck Labs, Inc. | -2.38 Million USD | 10202.977% |
| AlloVir, Inc. | -398 Thousand USD | 60641.709% |
| BioVie Inc. | -229.37 Thousand USD | 105148.021% |
| Codexis, Inc. | 57.33 Million USD | -320.267% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -123652.491% |
| Agenus Inc. | 139.61 Million USD | -72.586% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -476191.757% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 137912.781% |
| Viridian Therapeutics, Inc. | -1 Million USD | 24004.365% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1151.337% |
| Immix Biopharma, Inc. | -5468.00 USD | 4406756.913% |
| Celcuity Inc. | -142.77 Thousand USD | 168869.787% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 844.404% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 669.394% |
| IN8bio, Inc. | -2.5 Million USD | 9734.386% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 195999.187% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -21433.155% |
| Liquidia Corporation | 14.6 Million USD | -1550.384% |
| Quantum-Si incorporated | 488 Thousand USD | -49276.23% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 37258.534% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 243.844% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1195.902% |
| United Therapeutics Corporation | 2.07 Billion USD | 88.36% |
| Solid Biosciences Inc. | -76.56 Million USD | 414.716% |
| Immuneering Corporation | -764.13 Thousand USD | 31633.048% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 22535.382% |
| uniQure N.V. | 2.21 Million USD | -10778.375% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 12781.895% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 59153.501% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 361.712% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 4819220.0% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 19269.133% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -21137.462% |
| Cue Biopharma, Inc. | -32.6 Million USD | 838.97% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1152.347% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1302.615% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | -9000.00 USD | 2677388.889% |
| Elevation Oncology, Inc. | -39 Thousand USD | 617935.897% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immunome, Inc. | -8.9 Million USD | 2805.243% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 12848.995% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 137789.143% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 9119.408% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 10110.636% |
| Altimmune, Inc. | -65.37 Million USD | 468.586% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -59839.303% |
| Rallybio Corporation | -150 Thousand USD | 160737.333% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 5144.086% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -9651.356% |
| Moolec Science SA | -143.3 Thousand USD | 168242.075% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 730269.697% |
| NeurAxis, Inc. | 2.15 Million USD | -11072.419% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -71.863% |
| Lumos Pharma, Inc. | 2 Million USD | -11905.78% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 137789.143% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 228116.087% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 20129.593% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -661.104% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -27849.728% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 629.016% |
| argenx SE | 1.1 Billion USD | 78.263% |
| Neurogene Inc. | -3.26 Million USD | 7486.757% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -72.933% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 438201.818% |
| CervoMed Inc. | -1.29 Million USD | 18726.389% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 6626.436% |
| Sesen Bio, Inc. | 40 Million USD | -502.39% |
| AnaptysBio, Inc. | 14.78 Million USD | -1530.174% |
| Design Therapeutics, Inc. | -537 Thousand USD | 44970.764% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 56529.977% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -11128.145% |
| Achilles Therapeutics plc | -4.73 Million USD | 5192.843% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 248508.247% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 23448.45% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -560262.791% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 29413.382% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1831350.95% |
| Palisade Bio, Inc. | 246 Thousand USD | -97849.593% |
| Beam Therapeutics Inc. | -59.67 Million USD | 503.801% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 81229.966% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 6083.456% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 2618.879% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1611.335% |
| Athira Pharma, Inc. | -969 Thousand USD | 24966.46% |
| Vaccinex, Inc. | -16 Million USD | 1605.599% |
| HCW Biologics Inc. | -574.82 Thousand USD | 42018.222% |
| XOMA Corporation | 3.86 Million USD | -6140.767% |
| Nektar Therapeutics | 53.47 Million USD | -350.57% |
| Arvinas, Inc. | 71.8 Million USD | -235.593% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 388.705% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 483.841% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 74931.056% |
| Rezolute, Inc. | -36 Thousand USD | 669422.222% |
| Clene Inc. | 533 Thousand USD | -45107.505% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 18766143.614% |
| BeyondSpring Inc. | 1.75 Million USD | -13661.051% |
| Synlogic, Inc. | -1.92 Million USD | 12623.701% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 651332.432% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 3905.37% |
| Peak Bio, Inc. | 367.76 Thousand USD | -65418.301% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1370.664% |
| Krystal Biotech, Inc. | 47.6 Million USD | -406.157% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -70.781% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -4695.144% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 9406.127% |
| MannKind Corporation | 136.19 Million USD | -76.925% |
| Ikena Oncology, Inc. | -50.49 Million USD | 577.216% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -121.438% |
| Gossamer Bio, Inc. | -4.38 Million USD | 5595.006% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 95717.46% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4819220.0% |
| Legend Biotech Corporation | 140.92 Million USD | -70.977% |
| Mural Oncology plc | -2.56 Million USD | 9486.677% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 43830.672% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 241056.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1061.01% |
| REGENXBIO Inc. | 53.02 Million USD | -354.385% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 4598.005% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 125353.281% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 14012.009% |
| Vaxart, Inc. | -60.76 Million USD | 496.551% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 91794.954% |
| Cellectis S.A. | 18 Thousand USD | -1338544.444% |
| Longeveron Inc. | 221 Thousand USD | -108929.864% |
| Repare Therapeutics Inc. | -80.07 Million USD | 400.932% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 77.954% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 18721.02% |
| Revolution Medicines, Inc. | -399.66 Million USD | 160.29% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 688545.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -491646.939% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 97.2% |
| Denali Therapeutics Inc. | -93.34 Million USD | 358.135% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 962038.6% |
| Veru Inc. | 7.56 Million USD | -3084.751% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 159673.51% |
| Cingulate Inc. | -582.91 Thousand USD | 41436.174% |
| Passage Bio, Inc. | -3.72 Million USD | 6575.571% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 2000731.02% |
| Exicure, Inc. | -1.42 Million USD | 17032.959% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 63012.794% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -8814.391% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 160.29% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 47099.756% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -253.692% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 161159.309% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 506.979% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -61525.575% |
| OmniAb, Inc. | 14.66 Million USD | -1542.844% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1105.202% |
| Lipocine Inc. | -2.85 Million USD | 8552.171% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 13174.118% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 4323.593% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 16096.643% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -219.927% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 370801.538% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -185.845% |
| Ocugen, Inc. | -33.53 Million USD | 818.478% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 7720.367% |
| Q32 Bio Inc. | 578 Thousand USD | -41587.889% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 91026.792% |
| Alumis Inc. Common Stock | -1.28 Million USD | 18866.044% |
| Equillium, Inc. | 35.95 Million USD | -570.104% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 14215.759% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -48025.845% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 5828740.542% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 93133.205% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -56902.404% |
| Dominari Holdings Inc. | 2.03 Million USD | -11717.361% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 131431.927% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1872.387% |
| Bio-Techne Corporation | 773.07 Million USD | 68.831% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1291.281% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 47.708% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 20712.147% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1104.821% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1959.981% |
| Nkarta, Inc. | -5.86 Million USD | 4205.572% |
| BioCardia, Inc. | -7.24 Million USD | 3423.99% |
| Iterum Therapeutics plc | -1.75 Million USD | 13868.914% |